+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Topiramate"

Grand Mal Seizure Treatment Global Market Report 2024 - Product Thumbnail Image

Grand Mal Seizure Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Obesity - Pipeline Insight, 2024 - Product Thumbnail Image

Obesity - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 260 Pages
  • Global
From
From
From
From
Loading Indicator

Topiramate is a drug used to treat a variety of neurological conditions, including epilepsy, migraine, and bipolar disorder. It is classified as an anticonvulsant and antiepileptic drug, and is used to reduce the frequency of seizures and to prevent migraine headaches. It is also used to treat bipolar disorder, as it can help to reduce the frequency and severity of manic episodes. Topiramate is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological conditions. Topiramate is available in both generic and brand-name formulations, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. It is typically taken once or twice daily, depending on the condition being treated. Side effects of topiramate include dizziness, drowsiness, and nausea. The market for topiramate is highly competitive, with a number of major pharmaceutical companies offering the drug. Some of the companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, and Novartis. Show Less Read more